Nottingham life sciences firm breaks through £1m export barrier
Nottingham-based leading life sciences firm XenoGesis has reported a 78% increase in its exports from last year, with half of its revenue now coming from overseas.
In the financial year ending March 2019, 50% (£1.25m) of all the BioCity-based firm's revenue came from overseas clients, with its largest markets being in Europe.
XenoGesis’ international client base also includes the USA, South Africa and New Zealand.
Richard Weaver, founder and chief executive of XenoGesis, said: “The international growth we have seen highl... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...